跳到主要內容

Keyt Bruce 的 Form 4 申報

IGM Biosciences, Inc.(IGMS),2022/8/22 申報

申報編號
0001209191-22-047085
申報時間
2022/8/22
交易日
2022/8/18-8/22
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 6 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $55.4 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Keyt BruceCIK 0001787362高階主管(科學長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/8/18Common StockM行使選擇權取得+10,000$0.93+$9,30049,489直接
2022/8/18Common StockS賣出處分−10,000$22.54F2−$225,40039,489直接
2022/8/19Common StockM行使選擇權取得+8,700$0.93+$8,09148,189直接
2022/8/19Common StockS賣出處分−8,700$22.82F3−$198,53439,489直接
2022/8/22Common StockM行使選擇權取得+6,300$0.93+$5,85945,789直接
2022/8/22Common StockS賣出處分−6,300$20.71F4−$130,47339,489直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/8/18Common StockM行使選擇權處分−10,000$0.00$0123,756直接
2022/8/19Common StockM行使選擇權處分−8,700$0.00$0115,056直接
2022/8/22Common StockM行使選擇權處分−6,300$0.00$0108,756直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $22.35 to $22.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple trades at prices ranging from $22.40 to $23.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $20.50 to $21.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)